Parschauer Karah Herdman

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
27
Insider Sells Sum
$9.19M

Insider Activity of Parschauer Karah Herdman

According to the SEC Form 4 filings, Parschauer Karah Herdman, being in a position of

  1. director at Evolus, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11931 share for $156,733,
    over all time since 2024-01-30, has bought 0 shares, and sold 11931 share for $156,733.

The largest sale of all time was on 2020-08-17 and amounted to 12370 shares of Ultragenyx Pharmaceutical Inc. for $1.09M.

Biography of Parschauer Karah Herdman

No biography is available at this moment.

2024-06-12SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Legal Officer
9,806
0.0128%
$45.00$441,270+13.06%
2024-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Legal Officer
3,756
0.0046%
$53.76$201,923-12.28%
2024-01-30SaleEvolus, Inc.
EOLS
director
11,931
0.0211%
$13.14$156,733+3.61%
2023-05-04SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Legal Officer
4,378
0.0061%
$45.00$197,010-3.6%
2023-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Legal Officer
3,161
0.0045%
$45.25$143,035-7.47%
2022-03-07SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Legal Officer
5,140
0.0074%
$62.95$323,563-24.95%
2022-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Legal Officer
2,886
0.0041%
$66.62$192,265-29.29%
2021-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
310
0.0005%
$81.14$25,153-17.23%
2021-09-08SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
7,336
0.0106%
$100.65$738,368-31.73%
2021-06-10SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
1,329
0.002%
$100.00$132,900-19.8%
2021-05-06SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
313
0.0005%
$113.67$35,579-29.17%
2021-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
3,970
0.0057%
$138.17$548,535-38.37%
2020-10-30SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
9,903
0.0153%
$100.12$991,488+6.18%
2020-10-28SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
97
0.0002%
$100.00$9,700+12.26%
2020-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
325
0.0005%
$88.00$28,600+15.06%
2020-10-08SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
10,000
0.0156%
$95.00$950,000+12.94%
2020-10-06SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
10,000
0.0157%
$90.00$900,000+19.98%
2020-09-23SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
10,000
0.0169%
$85.00$850,000+28.9%
2020-08-17SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
12,370
0.0206%
$88.43$1.09M+21.8%
2020-05-18SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and General Counsel
2,722
0.0047%
$74.72$203,374+46.65%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.